Listas de seguimiento Ideas ProPicks IA Filtro Explorador de datos Gráficos Trabajo guardado

Huons Global Co Ltd

KOSDAQ:A084110

Corea del Sur / Salud / Productos farmacéuticos

Visión general

Finanzas históricas a 5 años

Precio

40.650,00 KRW


Key Metrics	Latest
Total Revenue	813,5 B
Adjusted EBITDA	137,7 B
EBITDA Margin	16,9%
Net Profit Margin	9,2%
Total Assets	1.405,9 B
Total Debt	297,4 B

5Y Historical Financial Statements

Summary Financials


Summary Financials

	Fiscal Year Ending					Latest	Year-to-date Ending
(in millions)	Dec-20	Dec-21	Dec-22	Dec-23	Dec-24	12 Months	Dec-23	Dec-24

Revenue	523,047.74	574,647.70	664,364.72	758,379.66	813,460.52	813,460.52	758,379.66	813,460.52
% Growth		0.10	0.16	0.14	0.07			0.07

Adjusted EBITDA	114,835.07	105,450.20	120,375.79	151,928.85	137,667.19	137,667.19	151,928.85	137,667.19
% Margin	0.22	0.18	0.18	0.20	0.17	0.17	0.20	0.17

Adjusted EBIT	89,248.77	76,129.28	86,734.61	115,948.63	97,355.86	97,355.86	115,948.63	97,355.86
% Margin	0.17	0.13	0.13	0.15	0.12	0.12	0.15	0.12

Adjusted Net Income	78,572.16	40,296.03	27,237.54	91,089.56	74,892.30	74,892.30	91,089.56	74,892.30
% Margin	0.15	0.07	0.04	0.12	0.09	0.09	0.12	0.09

Adjusted Basic EPS	6,573.87	3,242.33	2,216.34	7,437.41	6,135.75	6,135.75	7,437.41	6,135.75

Cálculos de apoyo

Income Statement

Balance Sheet

Statement of Cashflows


Income Statement
						Original
KRW	Fiscal Year Ending					Latest	Year-to-date Ending
(in millions)	Dec-20	Dec-21	Dec-22	Dec-23	Dec-24	Dec-24	Dec-23	Dec-24
	FY - 4	FY - 3	FY - 2	FY - 1	FY	LTM	YTD-1	YTD

Revenue	523,048	574,648	664,365	758,380	813,461	813,461	758,380	813,461
% Growth	NA	9.9%	15.6%	14.2%	7.3%			7.3%

Cost of Revenue	(232,298)	(251,676)	(299,121)	(340,576)	(393,488)	(393,488)	(340,576)	(393,488)
Gross Profit	290,749	322,971	365,244	417,803	419,973	419,973	417,803	419,973
% Revenue	55.6%	56.2%	55.0%	55.1%	51.6%	51.6%	55.1%	51.6%

Research and Development	(38,428)	(45,815)	(52,545)	(59,588)	(65,758)	(65,758)	(59,588)	(65,758)
Selling and Marketing	(95,914)	(123,666)	(139,270)	(153,830)	(161,003)	(161,003)	(153,830)	(161,003)
General and Admin	(62,314)	(71,087)	(79,829)	(81,462)	(87,864)	(87,864)	(81,462)	(87,864)
Other Inc / (Exp)	19,191	(13,963)	(87,914)	(2,731)	(13,957)	(13,957)	(2,731)	(13,957)
Total Operating Exp	(177,465)	(254,530)	(359,558)	(297,610)	(328,583)	(328,583)	(297,610)	(328,583)

Operating Income	113,285	68,442	5,686	120,193	91,390	91,390	120,193	91,390
% Revenue	21.7%	11.9%	0.9%	15.8%	11.2%	11.2%	15.8%	11.2%

Interest Expense	(1,492)	(4,969)	(5,031)	(561)	(1,026)	(1,026)	(561)	(1,026)
Pre-tax Income	111,793	63,473	655	119,633	90,364	90,364	119,633	90,364
Earnings of Discontinued Ops.	0	(889)	(378)	0	0	0	0	0
Provision for Taxes	(20,750)	(30,513)	(33,740)	(27,005)	(23,236)	(23,236)	(27,005)	(23,236)
Net Income to Company	91,043	32,071	(33,463)	92,628	67,127	67,127	92,628	67,127
% Margin	17.4%	5.6%	-5.0%	12.2%	8.3%	8.3%	12.2%	8.3%

Minority Interest in Earnings	(48,347)	(28,076)	(26,791)	(54,245)	(41,336)	(41,336)	(54,245)	(41,336)
Net Income to Stockholders	42,696	3,995	(60,254)	38,384	25,791	25,791	38,384	25,791

Preferred Dividends	0	0	0	0	0	0	0	0
Other Adj.	0	889	378	0	0	0	0	0

Net Income to Common	42,696	4,883	(59,876)	38,384	25,791	25,791	38,384	25,791
% Margin	8.2%	0.8%	-9.0%	5.1%	3.2%	3.2%	5.1%	3.2%

As Reported
Basic EPS (Continuing Ops)	3,572.23	392.93	(4,872.17)	3,134.00	2,113.00	2,113.00	3,134.00	2,113.00
Diluted EPS (Continuing Ops)	3,572.23	392.93	(4,872.17)	3,134.00	2,113.00	2,113.00	3,134.00	2,113.00

WA Basic Shares Out.	11.95	12.43	12.29	12.25	12.21	12.21	12.25	12.21
WA Diluted Shares Out.	11.95	12.43	12.29	12.25	12.21	12.21	12.25	12.21

EBITDA, EBIT Reconciliation
EBT, Incl. Unusual Items	111,793	63,473	655	119,633	90,364	90,364	119,633	90,364
Addback: Net Interest Expense	1,492	4,969	5,031	561	1,026	1,026	561	1,026
Addback: Other Non Operating Expenses, Total	(7,184)	(3,428)	(980)	(2,165)	(4,527)	(4,527)	(2,165)	(4,527)
Addback: Depreciation & Amortization	25,586	29,321	33,641	35,980	40,311	40,311	35,980	40,311
Addback: Restructuring Charges	0	0	0	0	0	0	0	0
Addback: Merger / Acquisition Expenses	0	0	0	0	0	0	0	0
Addback: Goodwill Impairment	0	0	0	0	0	0	0	0
Addback: Gain (Loss) On Sale Of Invest.	(16,895)	(2,363)	4,947	(2,468)	322	322	(2,468)	322
Addback: Gain (Loss) On Sale Of Assets	(477)	(10,494)	714	61	(5)	(5)	61	(5)
Addback: Asset Writedown	519	23,972	76,368	328	10,176	10,176	328	10,176
Addback: In Process R&D Expenses	0	0	0	0	0	0	0	0
Addback: Insurance Settlements	0	0	0	0	0	0	0	0
Addback: Legal Settlements	0	0	0	0	0	0	0	0
Addback: Other Unusual Items	0	0	0	0	0	0	0	0
Adjusted EBITDA	114,835	105,450	120,376	151,929	137,667	137,667	151,929	137,667
% Margin	22.0%	18.4%	18.1%	20.0%	16.9%	16.9%	20.0%	16.9%

Adjusted EBIT	89,249	76,129	86,735	115,949	97,356	97,356	115,949	97,356
% Margin	17.1%	13.2%	13.1%	15.3%	12.0%	12.0%	15.3%	12.0%

Adjusted Net Income Reconciliation
Net Income to Company	91,043	32,071	(33,463)	92,628	67,127	67,127	92,628	67,127
Addback: Unusual Items	(16,852)	11,115	82,028	(2,079)	10,493	10,493	(2,079)	10,493
Less: Tax Benefit of Unusual Items (26%)	4,382	(2,890)	(21,327)	541	(2,728)	(2,728)	541	(2,728)
Adjusted Net Income	78,572	40,296	27,238	91,090	74,892	74,892	91,090	74,892
% Margin	15.0%	7.0%	4.1%	12.0%	9.2%	9.2%	12.0%	9.2%

Error de carga

Huons Global Co Ltd

KOSDAQ:A084110

Corea del Sur / Salud / Productos farmacéuticos

Finanzas históricas a 5 años